Five early-career researchers have been awarded four-year fellowships under the LUMC Junior Principal Investigator (PI) Programme 2025. Each receives €850,000 to launch an independent research line within LUMC, with a strong emphasis on translating scientific insight into clinical application.
This year’s awardees include researchers working on personalised interventions for cardiometabolic diseases, new immunotherapies targeting B cells, brain waste clearance mechanisms, host–pathogen interactions, and chronic inflammation in IBD. The diversity of topics reflects LUMC’s focus on high-impact research that cuts across traditional disciplinary boundaries.
The programme is designed to accelerate the careers of talented postdocs by offering them full research independence, a formal PI status, and access to core facilities. It also strengthens LUMC’s position as a national leader in developing future scientific leadership. Each fellow will lead a small team and is expected to compete for follow-up funding through major national and international schemes.
The 2026 call is now open, and applicants are encouraged to align their proposals with LUMC’s strategic research themes.
Meet the 2025 fellows and learn how to apply for the next round here.
Leiden University Medical Center (LUMC), via its Cairelab initiative, together with the Dutch Police, have been declared winners of the National AI Challenge 2025, organized by...
Marieke Vinkenoog and Simon Christian Hansmann have been awarded the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog’s work on predictive modeling for donor eligibility and Hansmann’s identification of cancer cells linked to tumor recurrence exemplify the integration of advanced scientific methods to address pressing health challenges.
OEGSTGEEST, the Netherlands, September 04, 2025 / Biotech Newswire / -- Toxys, a leading innovator in animal-free toxicology solutions, announces that its flagship...